New Zealand markets closed

WPD Pharmaceuticals Inc. (WBIO.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.04500.0000 (0.00%)
As of 09:49AM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 5.10M
Enterprise value 4.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)117.46
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.42

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 30.00%
S&P500 52-week change 326.43%
52-week high 30.0450
52-week low 30.0450
50-day moving average 30.0450
200-day moving average 30.0450

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5113.44M
Implied shares outstanding 6113.44M
Float 8N/A
% held by insiders 139.62%
% held by institutions 10.00%
Shares short (31 May 2022) 4191
Short ratio (31 May 2022) 40.15
Short % of float (31 May 2022) 4N/A
Short % of shares outstanding (31 May 2022) 40.00%
Shares short (prior month 29 Apr 2022) 425.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 317 Jul 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -230.98k
Net income avi to common (ttm)5.97M
Diluted EPS (ttm)-0.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)143.46k
Total cash per share (mrq)0
Total debt (mrq)283.26k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.36
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-889.79k
Levered free cash flow (ttm)N/A